{
    "nct_id": "NCT06128278",
    "official_title": "Acute Equol Supplementation and Vascular Function in Postmenopausal Women With and Without CKD",
    "inclusion_criteria": "1. Postmenopausal (50-69 y) women\n2. Women with CKD including stage 3-4 (eGFR 15-59 ml/min/1.73m2) determined by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 equation\n3. Women without CKD (eGFR >60 ml/min/1.73m2) must be healthy (free from hypertension, kidney disease, CVD, diabetes, and other chronic disease as assessed by self-report, medical history, and screening labs).\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 50 Years\nMust have maximum age of 69 Years",
    "exclusion_criteria": "1. Use of HRT or has used HRT for <6 months prior to enrollment\n2. Advanced CKD requiring dialysis\n3. History of kidney transplant\n4. Use of immunosuppressant medications (unless taking a stable dosage for a quiescent disease)\n5. Current tobacco or nicotine use or history of use in the last 12 months\n6. Antioxidant and/or omega-3 fatty acid use within the 2 weeks prior to testing\n7. Marijuana use within 2 weeks prior to testing\n8. Consumption of soy and soy-based products 3 days prior to testing\n9. Uncontrolled hypertension in CKD group (BP>140/90 mmHg)\n10. Atrial fibrillation\n11. Active infection or antibiotic therapy\n12. Hospitalization in the last month",
    "miscellaneous_criteria": ""
}